Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Bowers, Jolene R ^a   Driebe, Elizabeth M ^a   Nibecker, Jennifer L ^a   Wojack, Bette R ^b   Sarovich, Derek S ^c   Wong, Ada H ^d   Brzoska, Pius M ^d   Hubert, Nathaniel ^a   Knadler, Andrew ^a   Watson, Lindsey M ^c   Wagner, David M ^c   Furtado, Manohar R ^d   Saubolle, Michael ^b,e   Engelthaler, David M ^a   Keim, Paul S ^a,c  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b Laboratory Sciences of Arizona   (United States)

^c NORTHERN ARIZONA UNIVERSITY   (United States)

^d Life Technologies Corporation   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIUM ISOLATE; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; ADOLESCENT; ADULT; AGED; BACTERIAL GENE; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECT; FEMALE; GENETICS; GENOTYPE; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; TRANSPOSON;

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARIZONA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; INFANT; MACROLIDES; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84855882958     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-12     Document Type: Article

References (49)

1. Antibiotic selection pressure and macrolide resistance in nasopharyngeal streptococcus pneumoniae: a cluster-randomized clinical trial. Skalet AH, Cevallos V, Ayele B, Gebre T, Zhou Z, Jorgensen JH, Zerihun M, Habte D, Assefa Y, Emerson PM, et al. PLoS Med 2010 7 12 1000377 10.1371/journal.pmed.1000377 21179434
2. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Karlowsky JA, Lagace-Wiens PR, Low DE, Zhanel GG, Int J Antimicrob Agents 2009 34 4 375 379 10.1016/j.ijantimicag.2009.05.008 19560902
3. Clinical impact of antibiotic resistance in respiratory tract infections. Klugman KP, Int J Antimicrob Agents 2007 29 Suppl 1 6 10 17307654
4. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Lonks JR, Garau J, Gomez L, Xercavins M, de Ochoa Echaguen A, Gareen IF, Reiss PT, Medeiros AA, Clin Infect Dis 2002 35 5 556 564 10.1086/341978 12173129
5. Bacterial eradication in the treatment of otitis media. Dagan R, Leibovitz E, Lancet Infect Dis 2002 2 10 593 604 10.1016/S1473-3099(02)00394-8 12383609
6. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT year 5 (2003-2004). Farrell DJ, Couturier C, Hryniewicz W, Int J Antimicrob Agents 2008 31 3 245 249 10.1016/j.ijantimicag.2007.10.022 18178388
7. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F, Gilbert GL, Antimicrob Agents Chemother 2010 54 3 1152 1159 10.1128/AAC.01268-09 20065057
8. The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics. Mera RM, Miller LA, Amrine-Madsen H, Sahm DF, Microb Drug Resist 2009 15 4 261 268 10.1089/mdr.2009.0056 19857132
9. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, Peck KR, Lee NY, Yang Y, Chongthaleong A, et al. J Antimicrob Chemother 2004 53 3 457 463 10.1093/jac/dkh118 14963068 (Pubitemid 38380243)
10. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Reinert RR, Filimonova OY, Al-Lahham A, Grudinina SA, Ilina EN, Weigel LM, Sidorenko SV, Antimicrob Agents Chemother 2008 52 6 2260 2262 10.1128/AAC.01270-07 18378707 (Pubitemid 351758574)
11. High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07). de la Pedrosa EG, Baquero F, Loza E, Nadal-Serrano JM, Fenoll A, Del Campo R, Canton R, J Antimicrob Chemother 2009 64 6 1165 1169 10.1093/jac/dkp364 19837717
12. Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. McGee L, Klugman KP, Wasas A, Capper T, Brink A, Antimicrob Agents Chemother 2001 45 5 1595 1598 10.1128/AAC.45.5.1595-1598.2001 11302838 (Pubitemid 32374145)
13. Resistance of Streptococcus pneumoniae isolated from Lebanese patients between 2005 and 2009. Daoud Z, Kourani M, Saab R, Nader MA, Hajjar M, Rev Esp Quimioter 2011 24 2 84 90 21667000
14. Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002-2006. Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, Kaijalainen T, Lyytikainen O, Virolainen A, Antimicrob Agents Chemother 2009 53 5 2066 2073 10.1128/AAC.01464-08 19273677
15. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman KP, Emerg Infect Dis 2005 11 6 851 858 15963279 (Pubitemid 40720845)
16. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998 to 2004. Zhanel GG, Wang X, Nichol K, Nikulin A, Wierzbowski AK, Mulvey M, Hoban DJ, Int J Antimicrob Agents 2006 28 5 465 471 10.1016/j.ijantimicag.2006.08.005 17049211 (Pubitemid 44636174)
17. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. Farrell DJ, Morrissey I, Bakker S, Morris L, Buckridge S, Felmingham D, J Clin Microbiol 2004 42 2 764 768 10.1128/JCM.42.2.764-768.2004 14766850 (Pubitemid 38222659)
18. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. Toltzis P, Dul M, O'Riordan MA, Jacobs MR, Blumer J, Pediatr Infect Dis J 2006 25 1 19 24 10.1097/01.inf.0000195784.27503. f0 16395097 (Pubitemid 43361470)
19. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Bley C, van der Linden M, Reinert RR, Int J Antimicrob Agents 2011 37 5 425 431 10.1016/j.ijantimicag.2011.01.019 21419605
20. Genetic elements responsible for erythromycin resistance in streptococci. Varaldo PE, Montanari MP, Giovanetti E, Antimicrob Agents Chemother 2009 53 2 343 353 10.1128/AAC.00781-08 19001115
21. New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271. Del Grosso M, Camilli R, Libisch B, Fuzi M, Pantosti A, Antimicrob Agents Chemother 2009 53 3 1293 1294 10.1128/AAC.01066-08 19104015
22. CLSI, Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplemen. CLSI document M100-S18 Wayne, PA: Clinical and Laboratory Standards Institute 2008
23. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Enright MC, Spratt BG, Microbiology 1998 144 Pt 11 3049 3060 9846740 (Pubitemid 28515583)
24. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, O'Brien KL, Whitney CG, Cohen AL, Beall BW, Journal of clinical microbiology 2010 48 5 1611 1618 10.1128/JCM.02243-09 20220175
25. Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children. Dias CA, Teixeira LM, Carvalho Mda G, Beall B, J Med Microbiol 2007 56 Pt 9 1185 1188 17761481 (Pubitemid 47477190)
26. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. Pai R, Gertz RE, Beall B, J Clin Microbiol 2006 44 1 124 131 10.1128/JCM.44.1.124-131.2006 16390959 (Pubitemid 43100590)
27. Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations. Pimenta FC, Gertz RE Jr, Roundtree A, Yu J, Nahm MH, McDonald RR, Carvalho Mda G, Beall BW, J Clin Microbiol 2009 47 7 2353 2354 10.1128/JCM.00704-09 19439547
28. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. Jin P, Xiao M, Kong F, Oftadeh S, Zhou F, Liu C, Gilbert GL, J Clin Microbiol 2009 47 8 2470 2474 10.1128/JCM.00484-09 19535528
29. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Brenciani A, Bacciaglia A, Vecchi M, Vitali LA, Varaldo PE, Giovanetti E, Antimicrob Agents Chemother 2007 51 4 1209 1216 10.1128/AAC.01484-06 17261630 (Pubitemid 46586795)
30. Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae. Del Grosso M, Scotto d'Abusco A, Iannelli F, Pozzi G, Pantosti A, Antimicrob Agents Chemother 2004 48 6 2037 2042 10.1128/AAC.48.6.2037-2042.2004 15155196 (Pubitemid 38691594)
31. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy. Pantosti A, D'Ambrosio F, Bordi E, Scotto D'Abusco A, Del Grosso M, Clin Microbiol Infect 2001 7 9 503 506 10.1046/j.1198-743x.2001.00298.x 11678935 (Pubitemid 34966139)
32. The mef(E)-carrying genetic element (mega) of Streptococcus pneumoniae: insertion sites and association with other genetic elements. Del Grosso M, Camilli R, Iannelli F, Pozzi G, Pantosti A, Antimicrob Agents Chemother 2006 50 10 3361 3366 10.1128/AAC.00277-06 17005818 (Pubitemid 44527511)
33. erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003. Cochetti I, Tili E, Mingoia M, Varaldo PE, Montanari MP, Antimicrob Agents Chemother 2008 52 4 1285 1290 10.1128/AAC.01457-07 18285489 (Pubitemid 351521989)
34. New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci. Cochetti I, Tili E, Vecchi M, Manzin A, Mingoia M, Varaldo PE, Montanari MP, J Antimicrob Chemother 2007 60 1 127 131 10.1093/jac/dkm120 17483548 (Pubitemid 47073285)
35. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, et al. J Infect Dis 2008 197 7 1016 1027 10.1086/528996 18419539 (Pubitemid 351590031)
36. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, J Infect Dis 2005 192 11 1988 1995 10.1086/498043 16267772 (Pubitemid 41681898)
37. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, Hakenbeck R, Hryniewicz W, Lefevre JC, Tomasz A, et al. J Clin Microbiol 2001 39 7 2565 2571 10.1128/JCM.39.7.2565-2571.2001 11427569 (Pubitemid 32606233)
38. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Jenkins SG, Brown SD, Farrell DJ, Ann Clin Microbiol Antimicrob 2008 7 1 10.1186/1476-0711-7-1 18190701 (Pubitemid 351344460)
39. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000-2004) of the PROTEKT US Study. Farrell DJ, File TM, Jenkins SG, J Clin Microbiol 2007 45 2 290 293 10.1128/JCM.01653-06 17093012
40. Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons. Calatayud L, Ardanuy C, Tubau F, Rolo D, Grau I, Pallares R, Martin R, Linares J, J Clin Microbiol 2010 48 4 1310 1316 10.1128/JCM.01868-09 20147647
41. Molecular characterization of erm(B)- and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010. Li Y, Tomita H, Lv Y, Liu J, Xue F, Zheng B, Ike Y, J Appl Microbiol 2011 110 1 254 265 10.1111/j.1365-2672.2010.04875.x 20961364
42. Clonality behind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland. Siira L, Jalava J, Tissari P, Vaara M, Kaijalainen T, Virolainen A, European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 2011 14757004
43. The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271. Del Grosso M, Northwood JG, Farrell DJ, Pantosti A, Antimicrob Agents Chemother 2007 51 11 4184 4186 10.1128/AAC.00598-07 17709465 (Pubitemid 350057826)
44. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Rzeszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG, Int J Antimicrob Agents 2004 24 2 95 104 10.1016/j.ijantimicag. 2004.03.008 15288306 (Pubitemid 38993686)
45. Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations. Noreddin AM, Roberts D, Nichol K, Wierzbowski A, Hoban DJ, Zhanel GG, Antimicrob Agents Chemother 2002 46 12 4029 4034 10.1128/AAC.46.12.4029-4034.2002 12435719 (Pubitemid 35403292)
46. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG, J Antimicrob Chemother 2007 60 4 733 740 10.1093/jac/dkm273 17673477 (Pubitemid 47434250)
47. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. Reingold A, Hadler J, Farley MM, Harrison GL, Lynfield R, Besser J, Bennett N, Thomas A, Schaffner W, Beall B, Pilishvili T, Whitney CG, Moore M, Burton DC, MMWR Morb Mortal Wkly Rep 2005 54 36 893 897 16163262
48. Mayers DL, Lerner SA, Ouellette M, Sobel JD, Antimicrobial drug resistanc Totowa, N.J.: Humana Press 2009
49. Rapid pneumococcal evolution in response to clinical interventions. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, et al. Science 2011 331 6016 430 434 10.1126/science.1198545 21273480